Microbiome–Tumor–Host Interactions in Cancer Therapy: From Chemoresistance Mechanisms to Engineered Living Medicines
This review synthesizes recent advances in pharmaco‐microbiomics, reframing cancer treatment in a hologenetic context, with host, tumor and microbiome acting as a tripartite entity. We comprehensively review microbiome‐mediated regulation of chemotherapeutic responses, encompassing both chemosensitization and resista...